| |
|
| |
|
|
| |
Apotransferrin |
|
| |
|
|
| |
A pharmaceutical human apotransferrin product for iron
binding therapy |
|
| |
Leni von Bonsdorff |
|
| |
|
|
| |
Development of a Pharmaceutical Apotransferrin
Product for Iron Binding Therapy |
|
| |
Leni von Bonsdorff, Hannele To¨
lo¨ , Enni Lindeberg ,Tuula Nyman ,Anna Harju, Jaakko Parkkinen
|
|
| |
Biologicals (2001) 29, 27–37 |
|
| |
|
|
| |
Effective binding of free iron by a single
intravenous dose of human apotransferrin in haematological stem cell transplant
patients. |
|
| |
Sahlstedt L, von Bonsdorff L, Ebeling
F, Ruutu T, Parkkinen J. |
|
| |
Br J Haematol. 2002 Nov;119(2):547-53 |
|
| |
|
|
| |
Clinical effects of apotransferrin on anemia
associated with hypotransferrinemia |
|
| |
Asano Y, Tomoyasu S, Yokoyama S, Nunoue
N, Tsuruoka N, Shimizu M, Makino Y.
|
|
| |
Rinsho Ketsueki. 1982 Dec;23(12):1841-6 |
|
| |
|
|
| |
Iron overload and
iron chelation |
|
| |
|
|
| |
Secondary iron overload |
|
| |
Kushner JP, Porter JP, Olivieri NF
|
|
| |
Hematology (Am Soc Hematol Educ Program). 2001;:47-61 |
|
| |
|
|
| |
Long-term outcome of continuous 24-hour deferoxamine
infusion via indwelling intravenous catheters in high-risk beta-thalassemia |
|
| |
Davis BA, Porter JB.
|
|
| |
Blood. 2000 Feb 15;95(4):1229-36 |
|
| |
|
|
| |
Iron Deficiency and Overload |
|
| |
Ernest Beutler,A.Victor Hoffbrand,and
James D.Cook
|
|
| |
Hematology (Am Soc Hematol Educ Program). 2003;:40-61 |
|
| |
|
|
